CR Pradeep, WJ Köstler, M Lauriola, RZ Granit… - Oncogene, 2011 - nature.com A large fraction of ductal carcinoma in situ (DCIS), a non-invasive precursor lesion of invasive breast cancer, overexpresses the HER2/neu oncogene. The ducts of DCIS are abnormally filled with cells that evade apoptosis, but the underlying mechanisms remain incompletely ... All 3 versions
[HTML] from oxfordjournals.orgBA Virnig… - Journal of the National Cancer …, 2011 - jnci.oxfordjournals.org In this issue of the Journal, Dick et al. (1) report on the comparative effectiveness of surgical and radiation therapy (RT) for ductal carcinoma in situ (DCIS). The authors found that rates of ipsilateral recurrence (both invasive and in situ) are lower for women undergoing mastectomy, ... Related articles - All 7 versions
JS Sung, SF Malak, P Bajaj, R Alis… - Radiology, 2011 - radiology.rsna.org Materials and Methods: This HIPAA-compliant study received institutional review board approval. The need for informed consent was waived. Retrospective review of the database yielded 670 screening breast MR studies obtained between January 2003 and September 2008 ...
[PDF] from hindawi.comVR Sarode, JS Han, DH Morris, Y Peng… - 2011 - downloads.hindawi.com ... Subtypes of Pure Ductal Carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with ... There is a paucity of data regarding molecular subtypes of pure ductal carcinoma in situ (pDCIS). ... View as HTML
KJ Van Zee - Annals of Surgery, 2011 - journals.lww.com We appreciate Dr Fujita's comments regarding our study, “The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy,” published in the Annals of Surgery in April 2010 (vol 251, pp ... Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
